Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel
Uitgebreid zoeken

BioPharma Terug naar discussie overzicht

HEB Memispherx

61 Posts
Pagina: 1 2 3 4 »» | Laatste | Omlaag ↓
  1. [verwijderd] 11 mei 2009 21:01

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    BRIEF-Hemispherx Biopharma announces public equity offerings

    May 11 (Reuters) - Hemispherx Biopharma, Inc : * Announces $18.3 million public equity offerings * Says offering priced at $1.10 per share

    ((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780)) ((For more news, please click here [HEB.A]))

    Sheff quote:

    Hemispherx Biopharma (HEB): Ampligen (Poly I: Poly C12U) NDA (three month PDUFA decision date delay was announced on 2/18/09 as additional data was submitted by HEB within three months of original decision date). Ampligen is an experimental treatment for chronic fatigue syndrome (which has no FDA-approved treatments) and the drug has an Orphan Drug Status with a PDUFA decision date of 5/25/09.

  5. [verwijderd] 15 mei 2009 20:18

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    quote:

    crackedtooth schreef:

    vooral goed voorbeeld..
    lekker opogelopen... extra hoog open... en daarna nieuws van verwatering
    Toch vandaag ruim 30% in de plus met een flink volume.
  6. welshterrier 5 18 mei 2009 21:08

    • welshterrier 5

      Lid sinds: 23 mrt 2004

      Laatste bezoek: 25 apr 2024

    • Aanbevelingen

      Ontvangen: 280

      Gegeven: 1037

    •    Aantal posts: 20.096

    quote:

    domus muris schreef:

    [quote=crackedtooth]
    vooral goed voorbeeld..
    lekker opogelopen... extra hoog open... en daarna nieuws van verwatering
    [/quote]

    Toch vandaag ruim 30% in de plus met een flink volume.
    nu bijna 2.00!!!!!!!!!!!!!!!!ruim 50 % in de plus
  8. [verwijderd] 18 mei 2009 23:53

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Pump en dump trade
    maar geniet ervan als je trader bent

    HEB inquiry

    Hemispherx Biopharma Comments On Market Activity

    PHILADELPHIA, May 15, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) stated that in view of the unusual market activity in the Company's stock, the NYSE Amex has contacted the Company and requested that the Company issue a public statement indicating as to whether there are any corporate developments which may explain the unusual activity. The Company stated that there have been no material events other than as disclosed in its recent press releases and its filings with the Securities and Exchange Commission that would explain the high volume market activity.

    finance.yahoo.com/news/Hemispherx-Bio...

  10. [verwijderd] 19 mei 2009 09:16

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    quote:

    welshterrier schreef:

    Er komt een eventuele goedkeuring aan voor de 25 e, dus het is geen pump en dump.............
    vlg mij
    wel geklooi, zo een sec message komt er niet iedere dag

    en nogmaals wil niet zeggen dat er geen winst gehaald kan worden erin
  16. welshterrier 5 19 mei 2009 18:18

    • welshterrier 5

      Lid sinds: 23 mrt 2004

      Laatste bezoek: 25 apr 2024

    • Aanbevelingen

      Ontvangen: 280

      Gegeven: 1037

    •    Aantal posts: 20.096

    quote:

    crackedtooth schreef:

    [quote=welshterrier ]
    2,30 al gezien
    [/quote]
    en heb je hem geshort dan?
    ben geen shorter, zou niet weten hoe dat moet
    pfffffffffffffffff
  18. [verwijderd] 23 mei 2009 17:50

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Chronic Fatigue Syndrome Treatment: FDA's Ampligen Decision Imminent
    Friday May 22, 2009

    Will the millions of people with chronic fatigue syndrome (CFS or ME/CFS) finally have an FDA-approved drug treatment? We should know soon, as the long-awaited decision on Ampligen (poly I: poly C12U) is due on or around May 25.

    Ampligen has languished in the "experimental" stage for 30 years. Then, in October 2007, Hemispherex Biopharma Inc. put in a New Drug Application for Ampligen as the first ever FDA approved treatment for ME/CFS. In July 2008, the company responded to questions sent back by the FDA, and the application was officially accepted. The decision was originally due in late February, but the FDA at that time announced it needed 3 more months. Now, it's just a matter of time before we hear yea or nay.

    Ampligen is an immume-system modulator that works by jump-starting your body's natural anti-viral pathway and regulating levels of Rnase L (a substance in your cells that attacks viruses), which can be high in people with ME/CFS. Studies show it's more effective and has far fewer side effects than other drugs in its class. Ampligen has also been studied as a possible treatment for AIDS, avian flu, and certain types of cancer.

    This drug has been available to certain U.S. clinics for several years, and there's a lot of evidence (both clinical and experiential) showing that it works. Some doctors claim they've seen improvement in 80% of people with ME/CFS who take Ampligen, and significant improvement in about 50%. They say a lot of seriously disabled people have even been able to go back to work because of it.

    Side effects are reportedly mild and include flu-like symptoms, dizziness and confusion. (After living with ME/CFS, would you even recognize those as side effects?)

    Here's more info from the manufacturer: Ampligen.

    chronicfatigue.about.com/b/2009/05/22...
  19. [verwijderd] 24 mei 2009 09:43

    • [verwijderd]

      Lid sinds: 01 jan 0001

      Laatste bezoek: 01 jan 0001

    • Aanbevelingen

      Ontvangen: 0

      Gegeven: 0

    •    Aantal posts: 0

    Misschien morgen positief nieuws?????????

    Als je de artikelen leest,kan het bijna niet meer mis,maar dat is al vaker gedacht.

    Stukje uit een artikel,je zou toch zeggen dat...................................nah,eerst maar eens zien.

    Vriendelijke groet.

    As reported in BioMedReports this past week, HEB is expecting to hear from the FDA this coming week as to whether Ampligen receives approval as a chronic fatigue syndrome treatment.

    With the "boats loads" of safety data available, Ampligen could quickly be developed for H1N1 flu strain, Piros said. He noted that Hemispherx already has been in discussions with the CDC about its product

    biomedreports.com/articles/most-popul...
61 Posts
Pagina: 1 2 3 4 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 465 6.840
AB InBev 2 5.285
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.579 46.258
ABO-Group 1 18
Acacia Pharma 9 24.692
Accell Group 151 4.129
Accentis 2 253
Accsys Technologies 22 8.892
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 160
ADMA Biologics 1 31
Adomos 1 126
AdUX 2 457
Adyen 13 16.227
Aedifica 2 829
Aegon 3.257 320.035
AFC Ajax 537 7.017
Affimed NV 2 5.751
ageas 5.843 109.777
Agfa-Gevaert 13 1.856
Ahold 3.536 73.980
Air France - KLM 1.024 34.308
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 466 12.765
Alfen 12 16.200
Allfunds Group 3 1.185
Almunda Professionals (vh Novisource) 651 4.246
Alpha Pro Tech 1 17
Alphabet Inc. 1 326
Altice 106 51.196
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.484 114.757
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.819 240.236
AMG 965 125.631
AMS 3 73
Amsterdam Commodities 303 6.516
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 382
Antonov 22.632 153.605
Aperam 91 14.109
Apollo Alternative Assets 1 17
Apple 5 313
Arcadis 251 8.613
Arcelor Mittal 2.023 318.590
Archos 1 1
Arcona Property Fund 1 266
arGEN-X 15 9.103
Aroundtown SA 1 176
Arrowhead Research 5 9.257
Ascencio 1 20
ASIT biotech 2 697
ASMI 4.107 37.645
ASML 1.762 76.815
ASR Nederland 18 4.122
ATAI Life Sciences 1 7
Atenor Group 1 330
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 29 10.646
Axsome Therapeutics 1 177
Azelis Group 1 49
Azerion 7 2.660

Macro & Bedrijfsagenda

  1. 25 april

    1. BASF Q1-cijfers
    2. Deutsche Bank Q1-cijfers
    3. Delivery Hero Q1-cijfers
    4. Nestlé Q1-cijfers
    5. Adyen Q1-cijfers
    6. Besi Q1-cijfers
    7. Flow Traders Q1-cijfers
    8. Sanofi Q1-cijfers
    9. Azelis Q1-cijfers
    10. Kinepolis Q1-cijfers
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht
Naar de hele agenda